Table 4.
Treatment | Regimen |
---|---|
Acute therapy | |
Corticosteroids | oral prednisone at 1 mg/ kg/day or methylprednisolone pulse IV (1000 mg daily for 3–5 days) |
Cyclophosphamide | daily oral dose (2 mg/kg/day) or by monthly intravenous pulse dose (e.g. starting at 750 mg/m2) |
Maintenance therapy | |
Azathioprine | 1–2 mg/kg daily |
Methotrexate | 20–25 mg/week |
Mycophenolate mofetil | 1–2 g daily |
Biological agents | |
Rituximab | 375 mg/m2/week for 4 weeks or 2 IV doses of 1 g each, administered 2 weeks apart |
Tumour necrosis factor-α blockers | |
Infliximab | single IV infusion (5 mg/kg) |
Etanercept | 25 mg twice weekly for 20 months, then 25 mg/kg, once weekly for 8 months |
IV, intravenous; PACNS, primary angiitis of the central nervous system.